GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Brain Scientific Inc (OTCPK:BRSF) » Definitions » PE Ratio

Brain Scientific (Brain Scientific) PE Ratio : At Loss (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Brain Scientific PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-06-05), Brain Scientific's share price is $0.75. Brain Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $-12.14. Therefore, Brain Scientific's PE Ratio for today is At Loss.

Brain Scientific's EPS (Diluted) for the three months ended in Dec. 2022 was $-1.94. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $-12.14.

As of today (2024-06-05), Brain Scientific's share price is $0.75. Brain Scientific's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 was $-13.59. Therefore, Brain Scientific's PE Ratio without NRI ratio for today is At Loss.

Brain Scientific's EPS without NRI for the three months ended in Dec. 2022 was $-1.36. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 was $-13.59.

Brain Scientific's EPS (Basic) for the three months ended in Dec. 2022 was $-1.94. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2022 was $-12.14.

Back to Basics: PE Ratio


Brain Scientific PE Ratio Historical Data

The historical data trend for Brain Scientific's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain Scientific PE Ratio Chart

Brain Scientific Annual Data
Trend Dec21 Dec22
PE Ratio
N/A At Loss

Brain Scientific Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
PE Ratio Get a 7-Day Free Trial N/A N/A At Loss At Loss At Loss

Competitive Comparison of Brain Scientific's PE Ratio

For the Medical Devices subindustry, Brain Scientific's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brain Scientific's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Brain Scientific's PE Ratio distribution charts can be found below:

* The bar in red indicates where Brain Scientific's PE Ratio falls into.



Brain Scientific PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Brain Scientific's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=0.75/-12.139
=-0.06(At Loss)

Brain Scientific's Share Price of today is $0.75.
Brain Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.14.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Brain Scientific  (OTCPK:BRSF) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Brain Scientific PE Ratio Related Terms

Thank you for viewing the detailed overview of Brain Scientific's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Brain Scientific (Brain Scientific) Business Description

Traded in Other Exchanges
N/A
Address
6700 Professional Parkway, Lakewood Ranch, FL, USA, 34240
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
Executives
Morgan C. Frank 10 percent owner 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02110
Manchester Explorer, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
James E Besser 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Jeb Partners, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Management Pr, Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Donald S Mackenzie director 5251 FISHER ISLAND DRIVE, MIAMI BEACH FL 33109
Thomas Olivier director C/O ARROWROOT ACQUISITION CORP., 4553 GLENCOE AVE SUITE 200, MARINA DEL REY CA 90292
Farid Anthony officer: Chief Technology Officer 12041 NW 49TH DRIVE, CORAL SPRINGS FL 33076
Daniel Danny Cloutier director 1200 MC GILL COLLEGE AVENUE, SUITE 1100, MONTREAL A8 H3G4G7
Bonnie-jeanne Gerety officer: Chief Financial Officer 5255 SOUTH TRIMBLE RD, SANDY SPRINGS GA 30342
Hassan Kotob director, 10 percent owner, officer: Chief Executive Officer 125 WILBUR PLACE, SUITE 170, C/O BRAIN SCIENTIFIC INC., BOHEMIA NY 11716
Mark Corrao officer: Chief Financial Officer 531 AIRPORT NORTH OFFICE PARK, FORT WAYNE IN 46825
Boris Goldstein director, 10 percent owner, officer: Chairman of the Board & EVP 45 WEST34 ST. 800, NEW YORK NY 10001
Nickolay V. Kukekov director 4524 WESTWAY AVE, DALLAS TX 75205

Brain Scientific (Brain Scientific) Headlines